Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135M Buy
917,800
+576,800
+169% +$93.8M 0.34% 38
2025
Q4
$66.5M Buy
+341,000
New +$81.2M 0.21% 61
2025
Q3
Sell
-73,700
Closed -$16.1M 3444
2025
Q2
$16.1M Buy
73,700
+2,500
+4% +$404K 0.07% 189
2025
Q1
$9.95M Buy
71,200
+33,400
+88% +$5.44M 0.06% 243
2024
Q4
$6.3M Buy
37,800
+9,700
+35% +$1.72M 0.03% 331
2024
Q3
$4.79M Buy
28,100
+19,100
+212% +$2.77M 0.02% 478
2024
Q2
$1.27M Sell
9,000
-1,100
-11% -$137K 0.01% 905
2024
Q1
$1.27M Buy
+10,100
New +$1.16M 0.01% 771
2023
Q3
Sell
-18,300
Closed -$2.18M 2906
2023
Q2
$2.18M Buy
+18,300
New +$1.89M 0.02% 577

Other funds holding ORCL

HRT Financial's ORCL Position: Q3 2025 in Review

HRT Financial sold out of Oracle (ORCL) in Q3 2025, closing a stake of 228,593 shares — an estimated $58.2M sold.

HRT Financial first reported a position in ORCL in Q3 2016 and held it in 23 quarters. The position peaked at $156M in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ORCL as of Q3 2025.

  • HRT Financial reported no remaining Oracle position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 228,593 Oracle shares in Q3 2025, an estimated $58.2M.
  • HRT Financial first reported a position in Oracle in Q3 2016 and held it in 23 quarters.
  • HRT Financial's Oracle position peaked at $156M in Q1 2022.
  • 3,820 funds tracked by Wall St. Rank held Oracle as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.